Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial

Peer Review reports

Original Submission
1 Jul 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
11 Jul 2022	Author responded	Author comments - Alejandro Llanos-Cuentas
Resubmission - Version 3
11 Jul 2022	Submitted	Manuscript version 3
Publishing
30 Jan 2023	Editorially accepted
28 Feb 2023	Article published	10.1186/s13104-023-06281-7

Back to article page